Targeted Bioscience
Private Company
Total funding raised: $9.5M
Overview
Targeted Bioscience is a private, commercial-stage company offering an integrated hardware and software platform for spatial profiling and digital pathology. Its core offerings include the Acculift™ Tissue Profiler for laser capture microdissection, the Targeted Labs Pro™ cloud platform for AI-driven data analysis and collaboration, and the Targeted EV™ kit for isolating extracellular vesicles from tissue. The company targets the growing research and diagnostic markets in oncology and spatial biology, providing tools to unlock molecular signatures from tissue with single-cell precision.
Technology Platform
Integrated spatial biology ecosystem comprising: 1) Acculift™ laser capture microdissection (LCM) hardware for single-cell tissue profiling, 2) Targeted Labs Pro™ cloud platform for AI-driven digital pathology and multi-omic data analysis, and 3) Targeted EV™ kit for isolating extracellular vesicles from tissue interstitial fluid.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Targeted Bioscience operates in a crowded and competitive landscape. In spatial profiling, it competes with leaders like 10x Genomics, Akoya Biosciences, and NanoString. In digital pathology software, it faces competition from Philips, Leica, Proscia, and Indica Labs. Its differentiation lies in its unique integration of LCM, EV isolation, and a cloud AI platform, offering a contiguous workflow that larger players with more fragmented portfolios may not provide.